Header cover image
  • Investing Ideas
  • /
  • Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

May & Baker Nigeria

Market Cap: ₦32.8b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦20.90

7D

10.0%

1Y

121.2%